Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 63; no. 11; pp. 3187 - 3194
Main Authors Boumans, Maria J. H., Thurlings, Rogier M., Gerlag, Danielle M., Vos, Koen, Tak, Paul P.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.11.2011
Wiley
Wiley Subscription Services, Inc
Subjects
Antibodies, Monoclonal, Murine-Derived - therapeutic use
Arthritis, Rheumatoid - drug therapy
Arthritis, Rheumatoid - immunology
Biological and medical sciences
Diseases of the osteoarticular system
Humans
Immunomodulators
Inflammatory joint diseases
Medical sciences
Pharmacology. Drug treatments
Rituximab
Treatment Outcome
Antineoplastic agent
Human
Immunopathology
Diseases of the osteoarticular system
Rheumatology
Rituximab
Autoimmune disease
Inflammatory joint disease
Immunomodulator
Chronic
Rheumatoid arthritis
Immunosuppressive agent
Immune system
Online AccessGet full text

Cover

More Information
Bibliography:Dr. Tak has received consulting fees from Genentech and Roche (less than $10,000 each).
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0004-3591
2326-5191
1529-0131
2326-5205
DOI:10.1002/art.30567